Netvax

RSS
Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Netvax has been withdrawn at the request of the marketing authorisation holder.

български (BG) (691.18 KB - PDF)

View

español (ES) (513.14 KB - PDF)

View

čeština (CS) (657.18 KB - PDF)

View

dansk (DA) (495.53 KB - PDF)

View

Deutsch (DE) (497.85 KB - PDF)

View

eesti keel (ET) (511.72 KB - PDF)

View

ελληνικά (EL) (691.94 KB - PDF)

View

français (FR) (496.07 KB - PDF)

View

italiano (IT) (495.88 KB - PDF)

View

latviešu valoda (LV) (665.3 KB - PDF)

View

lietuvių kalba (LT) (632.52 KB - PDF)

View

magyar (HU) (632.48 KB - PDF)

View

Malti (MT) (661.22 KB - PDF)

View

Nederlands (NL) (495.23 KB - PDF)

View

polski (PL) (652.17 KB - PDF)

View

português (PT) (512.51 KB - PDF)

View

română (RO) (610.38 KB - PDF)

View

slovenčina (SK) (656.59 KB - PDF)

View

slovenščina (SL) (646.29 KB - PDF)

View

Suomi (FI) (512.09 KB - PDF)

View

svenska (SV) (494.45 KB - PDF)

View

Product information

български (BG) (1.53 MB - PDF)

View

español (ES) (644.06 KB - PDF)

View

čeština (CS) (879.61 KB - PDF)

View

dansk (DA) (638.6 KB - PDF)

View

Deutsch (DE) (643.82 KB - PDF)

View

eesti keel (ET) (634.66 KB - PDF)

View

ελληνικά (EL) (1014.48 KB - PDF)

View

français (FR) (640.93 KB - PDF)

View

íslenska (IS) (647.66 KB - PDF)

View

italiano (IT) (636.47 KB - PDF)

View

latviešu valoda (LV) (892.65 KB - PDF)

View

lietuvių kalba (LT) (637.98 KB - PDF)

View

magyar (HU) (865.89 KB - PDF)

View

Malti (MT) (891.49 KB - PDF)

View

Nederlands (NL) (628.55 KB - PDF)

View

norsk (NO) (631.53 KB - PDF)

View

polski (PL) (859.67 KB - PDF)

View

português (PT) (636.23 KB - PDF)

View

română (RO) (641.64 KB - PDF)

View

slovenčina (SK) (858.29 KB - PDF)

View

slovenščina (SL) (855.5 KB - PDF)

View

Suomi (FI) (633.63 KB - PDF)

View

svenska (SV) (636.09 KB - PDF)

View
Latest procedure affecting product information: IB/0006
19/09/2013

български (BG) (526.17 KB - PDF)

View

español (ES) (505.35 KB - PDF)

View

čeština (CS) (523.19 KB - PDF)

View

dansk (DA) (509.13 KB - PDF)

View

Deutsch (DE) (519.36 KB - PDF)

View

eesti keel (ET) (508.5 KB - PDF)

View

ελληνικά (EL) (524.31 KB - PDF)

View

français (FR) (506.38 KB - PDF)

View

íslenska (IS) (503.46 KB - PDF)

View

italiano (IT) (506.08 KB - PDF)

View

latviešu valoda (LV) (523.1 KB - PDF)

View

lietuvių kalba (LT) (510.11 KB - PDF)

View

magyar (HU) (522.92 KB - PDF)

View

Malti (MT) (537.03 KB - PDF)

View

Nederlands (NL) (509.48 KB - PDF)

View

norsk (NO) (501.02 KB - PDF)

View

polski (PL) (524.71 KB - PDF)

View

português (PT) (507.63 KB - PDF)

View

română (RO) (507.21 KB - PDF)

View

slovenčina (SK) (523.3 KB - PDF)

View

slovenščina (SL) (519.18 KB - PDF)

View

Suomi (FI) (506.63 KB - PDF)

View

svenska (SV) (510.88 KB - PDF)

View

Product details

Name of medicine
Netvax
Active substance
Clostridium-perfringens-type-A alpha toxoid
International non-proprietary name (INN) or common name
adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
Species
Chicken
Anatomical therapeutic chemical veterinary (ATCvet) code
QI01AB08

Pharmacotherapeutic group

Immunologicals for aves

Therapeutic indication

For the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.

To reduce mortality and the incidence and severity of lesions caused by Clostridium-perfringens-type-A-induced necrotic enteritis. Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.

The onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.

The duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

Authorisation details

EMA product number
EMEA/V/C/000134
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
16/04/2009
Revision
2

Assessment history

This page was last updated on

Share this page